Archived Insight | November 8, 2018

New Laws Prohibit Restrictions on Pharmacists Discussing Drug Costs with Patients

On October 10, 2018, President Trump signed into law two bills that ban pharmacist “gag clauses,” sometimes included in contracts between pharmacies and pharmacy benefit managers (PBMs), which prohibit pharmacists from telling patients the price of drugs purchased without health insurance. Plan sponsors will need to take steps to ensure that their PBMs are in compliance with these new laws.

New Laws Prohibit Restrictions on Pharmacists Discussing Drug Costs with Patients

Get the full insight

See more insights

Human First Ai Forward

Human First. AI Forward. How to Ignite Innovation and Impact with AI

AI is reshaping business—are you ready? Get clarity & actionable steps in our upcoming webinar.

Technology, Benefits Administration, Communications, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Consulting Innovation, Corporate, Benefits Technology, ATC, Organizational Effectiveness, Health, Retirement

Register for the webinar

Business People In Meeting Having A Discussion

Reporting and Disclosure Guide for Benefit Plans 2026

The guide is an all-in-one resource that helps health and retirement plan sponsors meet compliance deadlines and avoid costly penalties.

Health, Retirement, Compliance, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Corporate, Pharmaceutical, ERISA@50

Get the Guide

Doctor Consulting With Patient During A Medical Appointment In Clinic

Q4 2025 Trends Focus: High-Cost Claims

Health plan sponsors can use data-driven strategies, preventive screenings and stop-loss coverage to lower costs and protect plan sustainability.

Health, Multiemployer Plans, Healthcare Industry, Public Sector, Higher Education, Architecture Engineering & Construction, Pharmaceutical, Corporate

Read Full Insight

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.